Investment in E.P. Medical Inc.
- Author: admin_epmed
- Category: NEWS
MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P. Medical Co., Ltd. (Representative Director: Yuji Matsumaru; Address: 3-11-5 Nihonbashi-Honcho, Chuo-ku, Tokyo), a company developing a transcutaneous transvascular electroencephalography device to identify focal location in intractable epilepsy.
Details are attachedThis PDF (external link)Please check.
Related posts
E.P. Medical website launched
In November 2021, the E.P. Medical website was launched.
- Category: NEWS
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…
- Category: NEWS
Series B funding from MedVenture Partners and DBJ Capital
We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and…
- Category: NEWS
Certified as a venture company originating from the University of Tsukuba
Our company has been certified as a venture company spun out of the University of Tsukuba. University of Tsukuba
- Category: NEWS